- Home
- CLDX vs BST Comparison
CLDX vs BST Comparison
Compare CLDX & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- BST
- Stock Information
- Founded
- CLDX N/A
- BST 2014
- Country
- CLDX United States
- BST United States
- Employees
- CLDX N/A
- BST N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BST Finance Companies
- Sector
- CLDX Health Care
- BST Finance
- Exchange
- CLDX Nasdaq
- BST Nasdaq
- Market Cap
- CLDX 1.3B
- BST 1.3B
- IPO Year
- CLDX 2008
- BST N/A
- Fundamental
- Price
- CLDX $23.36
- BST $38.40
- Analyst Decision
- CLDX Buy
- BST
- Analyst Count
- CLDX 9
- BST 0
- Target Price
- CLDX $50.00
- BST N/A
- AVG Volume (30 Days)
- CLDX 1.1M
- BST 95.1K
- Earning Date
- CLDX 08-07-2025
- BST 01-01-0001
- Dividend Yield
- CLDX N/A
- BST 7.81%
- EPS Growth
- CLDX N/A
- BST N/A
- EPS
- CLDX N/A
- BST N/A
- Revenue
- CLDX $7,559,000.00
- BST N/A
- Revenue This Year
- CLDX N/A
- BST N/A
- Revenue Next Year
- CLDX N/A
- BST N/A
- P/E Ratio
- CLDX N/A
- BST N/A
- Revenue Growth
- CLDX 24.49
- BST N/A
- 52 Week Low
- CLDX $14.40
- BST $27.87
- 52 Week High
- CLDX $47.00
- BST $39.59
- Technical
- Relative Strength Index (RSI)
- CLDX 64.61
- BST 65.36
- Support Level
- CLDX $20.76
- BST $37.91
- Resistance Level
- CLDX $23.55
- BST $38.60
- Average True Range (ATR)
- CLDX 1.22
- BST 0.36
- MACD
- CLDX 0.20
- BST -0.04
- Stochastic Oscillator
- CLDX 95.29
- BST 86.84
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.